James E. Flynn - Director, Director by Deputization, 10%+ Owner at Nuvalent, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, Director by Deputization, 10%+ Owner
Stock Symbol
NUVL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

James E. Flynn - trading volume in the past year for Nuvalent, Inc.

Holdings reported by James E. Flynn for Nuvalent, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 8.67M $578M $66.72 Jun 18, 2025 Through Deerfield Healthcare Innovations Fund, L.P.
Class A Common Stock 8.67M $578M $66.72 Jun 18, 2025 Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock 650K $43.4M $66.72 Jun 18, 2025 Deerfield Partners, L.P.
Class A Common Stock 2.65K $177K $66.72 Jun 18, 2025 Through Deerfield Management Company, L.P.
Stock Option (Right to Buy) 4.15K Jun 18, 2025 Through Deerfield Management Company, L.P. Class A Common Stock

Transactions reported by James E. Flynn for Nuvalent, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.